5 results
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... months or • RFB (dose ... Please refer to the table ... #management #opportunistic ... infections #HIVAIDS #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
be determined based ... adjusting the dose ... differential #algorithm #management ... #table #foamed ... icu #clinical #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... individualized, based ... injection) for 1–4 doses ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Methotrexate Toxicology 

Intravenous leucovorin (folinic acid) treatment serves as a cofactor necessary for synthesis of thymidylate
(folinic acid) treatment ... 6 hours and is based ... , up to 100 mg/m2 ... Toxicology #Toxicity #Management ... #Pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
please refer to Table ... 5 for dosing recommendation ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology